In addition, Kaplan-Meier survival analysis uncovered that the individuals with BC exhibiting reduced ZDHHC9 expression demonstrated superior OS, DSS, and PFI outcomes despite the non-significant p-value for PFI (Figure 3F). The gene discussed is ZDHHC9; the disease is breast cancer.